GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
15 Mar 2021 07:00 AM
RNS
Annual Report 2020 on Form 20-F
11 Mar 2021 02:25 PM
RNS
Director/PDMR Shareholding
11 Mar 2021 07:00 AM
RNS
GSK and Vir share positive VIR-7831 data in COVID
10 Mar 2021 01:23 PM
RNS
Director/PDMR Shareholding
09 Mar 2021 01:43 PM
RNS
Annual Financial Report
02 Mar 2021 03:48 PM
RNS
Director/PDMR Shareholding
01 Mar 2021 10:55 AM
RNS
Total Voting Rights
25 Feb 2021 12:00 PM
RNS
GSK announces otilimab data for treatment of COVID
24 Feb 2021 01:59 PM
RNS
Director/PDMR Shareholding
24 Feb 2021 12:13 PM
RNS
Holding(s) in Company
23 Feb 2021 09:03 AM
RNS
Director/PDMR Shareholding
22 Feb 2021 04:39 PM
RNS
Director/PDMR Shareholding
22 Feb 2021 10:40 AM
RNS
Sanofi and GSK initiate new Phase 2 study
19 Feb 2021 12:52 PM
RNS
Director/PDMR Shareholding
19 Feb 2021 12:31 PM
RNS
Director/PDMR Shareholding
19 Feb 2021 10:32 AM
RNS
Director/PDMR Shareholding
18 Feb 2021 09:59 AM
RNS
Director/PDMR Shareholding
17 Feb 2021 12:00 PM
RNS
GSK/Vir collaborate on antibodies for influenza
17 Feb 2021 09:00 AM
RNS
Director/PDMR Shareholding
15 Feb 2021 10:09 AM
RNS
Director/PDMR Shareholding
15 Feb 2021 09:15 AM
RNS
Director/PDMR Shareholding
12 Feb 2021 04:26 PM
RNS
Director/PDMR Shareholding
12 Feb 2021 04:23 PM
RNS
Director/PDMR Shareholding
12 Feb 2021 04:20 PM
RNS
Director/PDMR Shareholding
10 Feb 2021 05:05 PM
RNS
Director/PDMR Shareholding
10 Feb 2021 04:54 PM
RNS
Director/PDMR Shareholding
04 Feb 2021 11:15 AM
RNS
Director/PDMR Shareholding
03 Feb 2021 12:00 PM
RNS
Final Results
03 Feb 2021 07:00 AM
RNS
GSK/CureVac partner on new mRNA Covid-19 vaccines
01 Feb 2021 02:04 PM
RNS
Total Voting Rights
26 Jan 2021 04:26 PM
RNS
Director/PDMR Shareholding
22 Jan 2021 07:00 AM
RNS
FDA approves ViiV Healthcare's Cabenuva for HIV
20 Jan 2021 04:00 PM
RNS
Director/PDMR Shareholding
20 Jan 2021 03:50 PM
RNS
Director/PDMR Shareholding
20 Jan 2021 03:02 PM
RNS
Director/PDMR Shareholding
19 Jan 2021 06:02 PM
RNS
Director/PDMR Shareholding
18 Jan 2021 05:31 PM
RNS
Director/PDMR Shareholding
15 Jan 2021 04:00 PM
RNS
Director/PDMR Shareholding
15 Jan 2021 03:14 PM
RNS
Director/PDMR Shareholding
13 Jan 2021 01:45 PM
RNS
Director/PDMR Shareholding
11 Jan 2021 11:05 AM
RNS
Director/PDMR Shareholding
11 Jan 2021 09:16 AM
RNS
Director/PDMR Shareholding
04 Jan 2021 11:25 AM
RNS
Total Voting Rights
30 Dec 2020 11:52 AM
RNS
Director/PDMR Shareholding
23 Dec 2020 02:44 PM
RNS
Director/PDMR Shareholding
21 Dec 2020 07:00 AM
RNS
ViiV first long-acting HIV regimen approved in EU
11 Dec 2020 07:00 AM
RNS
Sanofi/ GSK update on COVID vaccine candidate
10 Dec 2020 05:51 PM
RNS
Director/PDMR Shareholding
10 Dec 2020 11:55 AM
RNS
Block Listing Application
09 Dec 2020 03:04 PM
RNS
Director/PDMR Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings